Xeltis

Eindhoven, The Netherlands

Xeltis is a clinical-stage medtech company with the world's most advanced polymer-based platform of restorative cardiovascular devices.

$13.6M raised

Aug 2023

Series D

Top Investors

European Investment BankKurma PartnersInvest-NLEQT Life SciencesYsios Capital

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Xeltis raised?

Xeltis has raised $13.6M in total funding. The most recent round was Series D. The last funding was announced in August 2023.

Who are Xeltis's investors?

Xeltis's investors include European Investment Bank, Kurma Partners, Invest-NL, EQT Life Sciences, Ysios Capital.

Where is Xeltis headquartered?

Xeltis is headquartered in Eindhoven, The Netherlands.

What does Xeltis do?

Xeltis is a clinical-stage medtech company with the world's most advanced polymer-based platform of restorative cardiovascular devices.

What stage is Xeltis at?

Xeltis is at the Series D stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated August 14, 2023.

MLA

"Xeltis — Funding & Investors." VCBacked, August 14, 2023, https://www.vcbacked.co/company/xeltis. Accessed June 3, 2026.

APA

VCBacked. (2023). Xeltis — Funding & Investors. Retrieved June 3, 2026, from https://www.vcbacked.co/company/xeltis

Wikipedia (cite web)

{{cite web |title=Xeltis — Funding & Investors |url=https://www.vcbacked.co/company/xeltis |website=VCBacked |access-date=June 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated August 14, 2023.